<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20288" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Deep Brain Stimulation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fariba</surname>
            <given-names>Kamron A.</given-names>
          </name>
          <aff>University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kamron Fariba declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20288.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Deep brain stimulation (DBS) was first approved in the 1990s for the treatment of movement disorders. DBS has the potential to offer symptom resolution for a variety of disease processes. DBS involves the placement of electrodes adjacent to deep structures in the brain. These electrodes are then connected, by a wire, to a pulse generator which is subcutaneously implanted into the chest wall. The pulse generator is controlled by a computer, which ultimately gives instructions to the electrodes to fire. This activity explains the application of DBS and reviews the role of the interprofessional team in improving care for patients undergoing deep brain stimulation.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for deep brain stimulation.</p></list-item><list-item><p>Summarize the risks associated with deep brain stimulation.</p></list-item><list-item><p>Outline the targeted structures for various deep brain stimulation indications.</p></list-item><list-item><p>Review the importance of collaboration and communication among the interprofessional team to ensure the appropriate selection of candidates for deep brain stimulation and to enhance postoperative management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20288&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20288">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20288.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Since the discovery of localized activation of the motor cortex in the late 19th century, electrical manipulation of the brain has frequently been the focus&#x000a0;of scientific investigations. Following the revelation of the electrical properties of the motor cortex, subsequent mapping of cortical function was completed. This was followed in the 1950s, by the identification of deep structures of the brain via intraoperative stimulation. Theories of treating neurologic disorders with&#x000a0;chronic stimulation began to emerge over the proceeding decade. By the 1970s, documentation&#x000a0;of the management of pain, movement disorders, and epilepsy through the application of chronic stimulation was made evident. Eventually, in the 1990s, by combining the technologies of the implantable pacemaker with chronically implanted deep electrodes, the discovery of deep brain stimulation (DBS) was made possible.<xref ref-type="bibr" rid="article-20288.r1">[1]</xref></p>
      </sec>
      <sec id="article-20288.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The deep brain stimulation (DBS) apparatus consists of electrodes implanted adjacent to specific deep brain structures, which are then connected&#x000a0;to a pacemaker-like machine (pulse generator) that is implanted on the chest wall, via a subcutaneous wire. Stimulation parameters are then&#x000a0;relayed by a computer to&#x000a0;the pulse generator, appropriating proper amplitudes, frequencies, and pulse width. Common structures targeted by DBS include the subthalamic nucleus (STN), globus pallidus interna (GPi), and the ventral intermediate nucleus of the thalamus (VIM).<xref ref-type="bibr" rid="article-20288.r2">[2]</xref></p>
        <p>The precise mechanism of the resultant therapeutic effects of deep brain stimulation remains unclear; however, theories are plenty. As implied by the recounting of the surplus of possible applications, stimulation of the deep brain structures influences a variety of circuits involved in neuronal functioning. Therapeutic effects are incumbent upon physiologic properties of cells, surface areas of stimulated structures, the amplitude and temporal properties of the stimulation, and lastly, the characteristics of the underlying pathophysiology of different disease states. Imaging and physiologic studies corroborate the hypothesis that the ultimate effect of deep brain stimulation is the increase of the firing of the targeted neurons.<xref ref-type="bibr" rid="article-20288.r1">[1]</xref></p>
      </sec>
      <sec id="article-20288.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Deep brain stimulation (DBS) is approved by the United States Food and Drug Administration (FDA) for the treatment of essential tremors, dystonia, Parkinson disease, and treatment-refractory obsessive-compulsive disease (OCD).<xref ref-type="bibr" rid="article-20288.r2">[2]</xref></p>
        <p>Since the nascent stages of its discovery, DBS technology has increasingly gained application and use. The initial implementation&#x000a0;of DBS was for the treatment of essential tremor (ET) and the tremor of Parkinson disease (PD).<xref ref-type="bibr" rid="article-20288.r3">[3]</xref><xref ref-type="bibr" rid="article-20288.r4">[4]</xref>&#x000a0;Studies indicate that stimulation of the &#x0201c;ventral intermediate nucleus of the thalamus, via DBS, results in the average tremor reduction of over 80%.&#x0201d;<xref ref-type="bibr" rid="article-20288.r5">[5]</xref><xref ref-type="bibr" rid="article-20288.r6">[6]</xref><xref ref-type="bibr" rid="article-20288.r7">[7]</xref>&#x000a0;Stimulation of the globus pallidus internus has demonstrated a reduction of major motor manifestations of PD, including, but not limited, to dopaminergic induced dyskinesias.<xref ref-type="bibr" rid="article-20288.r8">[8]</xref>&#x000a0;Stimulation of the GPi is believed to reduce parkinsonian akinesia and rigidity by normalizing the firing frequency of the dysfunctional GPi.<xref ref-type="bibr" rid="article-20288.r9">[9]</xref>&#x000a0;Improvement of gait, tremor, and bradykinesia has been shown via stimulation of the subthalamic nucleus.<xref ref-type="bibr" rid="article-20288.r10">[10]</xref><xref ref-type="bibr" rid="article-20288.r11">[11]</xref>&#x000a0;Stimulation of the parafascicular and sensory relay nuclei of the thalamus has demonstrated analgesic properties.<xref ref-type="bibr" rid="article-20288.r12">[12]</xref><xref ref-type="bibr" rid="article-20288.r13">[13]</xref></p>
        <p>In 1999, the first psychiatric indication for DBS was published.<xref ref-type="bibr" rid="article-20288.r2">[2]</xref>&#x000a0;Since that&#x000a0;initial publication, many studies focusing on DBS for treatment-resistant psychiatric illnesses have been performed.&#x000a0;More recently, DBS has been found to have beneficial effects in Tourette Syndrome, via stimulation of the centromedian-parafascicular complex of the thalamus, along with the GPi and the anterior limb of the internal capsule. Perhaps most notably is the application of DBS for obsessive-compulsive disorder (OCD) and treatment-refractory depression.<xref ref-type="bibr" rid="article-20288.r14">[14]</xref>&#x000a0;DBS of the subgenual cingulate white matter has demonstrated efficacy in the improvement of mood in those afflicted with treatment-resistant depression, whereas DBS of the bilateral anterior limbs of the internal capsules has shown a reduction of OCD-related symptoms.<xref ref-type="bibr" rid="article-20288.r15">[15]</xref>&#x000a0;Evidence demonstrating the resolution of OCD symptomatology by targeting&#x000a0;either the ventral capsule/ventral striatum&#x000a0;or the STN led to the FDA approval of DBS for treatment-refractory OCD, in 2009.<xref ref-type="bibr" rid="article-20288.r2">[2]</xref>&#x000a0;The first documented application of DBS for treatment-resistant depression (TRD) was in 2009. Hypothesized targets for the treatment of TRD are the subgenual anterior cingulate cortex, ventral capsule/ventral striatum, nucleus accumbens, and the medial forebrain bundle.<xref ref-type="bibr" rid="article-20288.r2">[2]</xref>&#x000a0;Future psychiatric indications that are currently being studied include addiction, autism, anorexia nervosa, anxiety disorders, and schizophrenia.</p>
      </sec>
      <sec id="article-20288.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Deep brain stimulation (DBS) has fairly minimal absolute contraindications. DBS is contraindicated in patients who cannot properly operate the neurostimulator. Once implanted, patients with deep brain stimulators should not undergo full-body magnetic resonance imaging scans (MRIs), transcranial magnetic stimulation, and diathermy.<xref ref-type="bibr" rid="article-20288.r16">[16]</xref></p>
      </sec>
      <sec id="article-20288.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>Proper DBS equipment includes a lead with electrodes, a wire, a pulse generator, along with the&#x000a0;corresponding&#x000a0;tools for brain surgery and chest wall implantation.<xref ref-type="bibr" rid="article-20288.r2">[2]</xref></p>
      </sec>
      <sec id="article-20288.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>The procedure requires specific personnel. Quintessential to the surgery is an experienced neurosurgeon, along with their associated staff. As DBS is currently indicated for mostly neurologic disorders, it is more likely that the referring physician will be a neurologist. However, for indications such as treatment-refractory OCD, a psychiatrist will often fill the role of the referring physician sometimes in discussion with a neurologist. Moreover, the referring physician, along with the neurosurgeon, will discuss the case and identify the structures of pertinence to be stimulated by the implanted device.<xref ref-type="bibr" rid="article-20288.r2">[2]</xref></p>
      </sec>
      <sec id="article-20288.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Prior to the procedure, the patient will need to be medically cleared to undergo surgery, to ensure that DBS is a safe and appropriate option. Once cleared, the patient will undergo brain-imaging studies to visualize locations for implantation of the electrodes.<xref ref-type="bibr" rid="article-20288.r16">[16]</xref></p>
      </sec>
      <sec id="article-20288.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Once underway, the surgical team will fit the patient with a special frame to immobilize head movement during the surgery. This&#x000a0;frame is called a stereotactic head frame. Surgery is commonly performed under general anesthesia, but local anesthesia is also a viable alternative. Intriguingly, the brain itself does not require an anesthetic itself, as it lacks pain receptors. The surgeon then implants a thin wire lead&#x000a0;to the structures that were identified pre-surgery. Tiny electrodes at the end of the wire will contact the aforementioned structures. The lead is then connected to a wire which runs just superficially to the skin, which ultimately connects to a pulse generator within the chest wall. Both the neurosurgeon and neurologist will closely monitor brain function throughout the procedure to ensure appropriate electrode placement.</p>
        <p>The subsequent chest wall surgery involves the placement of the pulse generator just under the skin near the clavicle. Unlike the preceding procedure, chest wall surgery requires general anesthesia. The pulse generator is then connected to a special remote control.<xref ref-type="bibr" rid="article-20288.r2">[2]</xref></p>
      </sec>
      <sec id="article-20288.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Of equal ambiguity is the side effect profile of deep brain stimulation. Whereas the&#x000a0;surgical complications implicated with deep brain stimulation, such as hemorrhage, surgical revision of hardware, and infection, are more apparent and objective, the assessment of psychiatric and neurologic&#x000a0;manifestations&#x000a0;of adverse effects tend to be more discreet and&#x000a0;protean, from patient to patient. This vagueness is multifactorial in origin. Firstly, patients may simply not relay these complaints to their respective physicians. Reciprocally, the physician, in turn, may not ask the appropriate questions in order to elucidate ongoing adverse side effects. It is plausible that even if side effects are reported, they may not be documented if they do not meet some arbitrary threshold level of severity. Moreover, it is sometimes hard to differentiate between pre-existing symptoms and comorbidities from&#x000a0;the precipitating side effects of DBS. Furthermore, certain side effects tend to manifest over time and occur with latency. An example of this insidious&#x000a0;onset is axial symptoms in Parkinson disease. Lastly, as science further evolves and behavioral derivatives of neurocircuitry are mapped out, it is possible that what was once celebrated as therapeutic gains from&#x000a0;DBS treatment, will now be regarded as red flags. For example, whereas the spontaneous onset of&#x000a0;initiative in STN-stimulated Parkinson disease patients was once applauded as progress, it is now, unfortunately, considered&#x000a0;to be the pathological manifestation&#x000a0;of disturbed impulse control.<xref ref-type="bibr" rid="article-20288.r17">[17]</xref>&#x000a0;However, current scientific literature demonstrates that deep brain stimulation is relatively safe overall and is associated with only minimal and perhaps negligible side effect profile. Nonetheless, the following includes a list of reported side effects: mild gait or speech disturbances, affective liability, worsened depression, seizure, difficulty concentrating, confusion, and headache.</p>
      </sec>
      <sec id="article-20288.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Deep brain stimulation has the potential for robust application, and has specifically been heralded as&#x000a0;offering "a new life for people with Parkinson disease."<xref ref-type="bibr" rid="article-20288.r16">[16]</xref> DBS has already been awarded FDA approval for essential tremor, dystonia, Parkinson disease, and treatment-refractory obsessive-compulsive disease. Ongoing studies are investigating the possible&#x000a0;off-label use in&#x000a0;addiction, autism, anorexia nervosa, anxiety disorders, and schizophrenia.</p>
      </sec>
      <sec id="article-20288.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The literature is abundant, with studies demonstrating the benefits of interprofessional&#x000a0;collaboration. Patient outcomes such as decreasing morbidity and mortality rates, optimizing medication dosages, and reducing preventable adverse drug events have been shown to improve via interprofessional collaboration.<xref ref-type="bibr" rid="article-20288.r18">[18]</xref>[Level 4] Not only does this benefit the patient, but it also benefits the health care workers, by increasing job satisfaction and reducing extra work.<xref ref-type="bibr" rid="article-20288.r18">[18]</xref>&#x000a0;Successful deep brain stimulation (DBS) requires integrative, collaborative communication, and care. An interprofessional DBS team should include an experienced surgeon (with expertise in functional neurosurgery), a movement disorder neurologist, psychiatrist, neuropsychologist, and neuropsychologist. The nurse plays an integral role in assisting the patient gain maximum benefit from the surgical intervention. All healthcare workers must be engaged and in sync for the patient to achieve optimal results.</p>
        <p>"This research was supported (in whole or part) by HCA Healthcare and/or an HCA Healthcare affiliated entity. The views expressed in this publication represent those of the author(s) and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities."</p>
      </sec>
      <sec id="article-20288.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20288&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20288">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20288/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20288">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20288.s14">
        <title>References</title>
        <ref id="article-20288.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perlmutter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mink</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Deep brain stimulation.</article-title>
            <source>Annu Rev Neurosci</source>
            <year>2006</year>
            <volume>29</volume>
            <fpage>229</fpage>
            <page-range>229-57</page-range>
            <pub-id pub-id-type="pmid">16776585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dougherty</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Deep Brain Stimulation: Clinical Applications.</article-title>
            <source>Psychiatr Clin North Am</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>385</fpage>
            <page-range>385-394</page-range>
            <pub-id pub-id-type="pmid">30098652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benabid</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Limousin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Payen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Benazzouz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.</article-title>
            <source>J Neurosurg</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-14</page-range>
            <pub-id pub-id-type="pmid">8592222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benabid</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gervason</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hommel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perret</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>de Rougemont</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus.</article-title>
            <source>Lancet</source>
            <year>1991</year>
            <month>Feb</month>
            <day>16</day>
            <volume>337</volume>
            <issue>8738</issue>
            <fpage>403</fpage>
            <page-range>403-6</page-range>
            <pub-id pub-id-type="pmid">1671433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benabid</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Benazzouz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Limousin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krack</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Long-term electrical inhibition of deep brain targets in movement disorders.</article-title>
            <source>Mov Disord</source>
            <year>1998</year>
            <volume>13 Suppl 3</volume>
            <fpage>119</fpage>
            <page-range>119-25</page-range>
            <pub-id pub-id-type="pmid">9827607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benazzouz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>ZG</given-names>
              </name>
              <name>
                <surname>Piallat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bouali-Benazzouz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Benabid</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat.</article-title>
            <source>Neuroscience</source>
            <year>2000</year>
            <volume>99</volume>
            <issue>2</issue>
            <fpage>289</fpage>
            <page-range>289-95</page-range>
            <pub-id pub-id-type="pmid">10938434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brice</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McLellan</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Suppression of intention tremor by contingent deep-brain stimulation.</article-title>
            <source>Lancet</source>
            <year>1980</year>
            <month>Jun</month>
            <day>07</day>
            <volume>1</volume>
            <issue>8180</issue>
            <fpage>1221</fpage>
            <page-range>1221-2</page-range>
            <pub-id pub-id-type="pmid">6104038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Postupna</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ruffo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effects of high-frequency stimulation in the internal globus pallidus on the activity of thalamic neurons in the awake monkey.</article-title>
            <source>J Neurophysiol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>89</volume>
            <issue>2</issue>
            <fpage>1150</fpage>
            <page-range>1150-60</page-range>
            <pub-id pub-id-type="pmid">12574488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boraud</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bezard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bioulac</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>High frequency stimulation of the internal Globus Pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey.</article-title>
            <source>Neurosci Lett</source>
            <year>1996</year>
            <month>Aug</month>
            <day>30</day>
            <volume>215</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-20</page-range>
            <pub-id pub-id-type="pmid">8880743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Burchiel</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hogarth</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Favre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hammerstad</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.</article-title>
            <source>Arch Neurol</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>554</fpage>
            <page-range>554-60</page-range>
            <pub-id pub-id-type="pmid">15824252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bastian</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Revilla</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Perlmutter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mink</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease.</article-title>
            <source>Mov Disord</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>1000</fpage>
            <page-range>1000-7</page-range>
            <pub-id pub-id-type="pmid">14502667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aiko</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shima</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hosokawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kitamura</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Altered local cerebral glucose utilization induced by electrical stimulations of the thalamic sensory and parafascicular nuclei in rats.</article-title>
            <source>Brain Res</source>
            <year>1987</year>
            <month>Apr</month>
            <day>07</day>
            <volume>408</volume>
            <issue>1-2</issue>
            <fpage>47</fpage>
            <page-range>47-56</page-range>
            <pub-id pub-id-type="pmid">3594230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittar</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Kar-Purkayastha</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Bear</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>TZ</given-names>
              </name>
            </person-group>
            <article-title>Deep brain stimulation for pain relief: a meta-analysis.</article-title>
            <source>J Clin Neurosci</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>515</fpage>
            <page-range>515-9</page-range>
            <pub-id pub-id-type="pmid">15993077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vingerhoets</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perrin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guex</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Villemure</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Burkhard</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Benkelfat</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ghika</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients.</article-title>
            <source>Neurology</source>
            <year>2002</year>
            <month>Nov</month>
            <day>12</day>
            <volume>59</volume>
            <issue>9</issue>
            <fpage>1427</fpage>
            <page-range>1427-9</page-range>
            <pub-id pub-id-type="pmid">12427897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aouizerate</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Martin-Guehl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cuny</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guehl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Amieva</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Benazzouz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fabrigoule</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Allard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rougier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burbaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tignol</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bioulac</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[Deep brain stimulation of the ventral striatum in the treatment of obsessive-compulsive disorder and major depression].</article-title>
            <source>Med Sci (Paris)</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>10</issue>
            <fpage>811</fpage>
            <page-range>811-3</page-range>
            <pub-id pub-id-type="pmid">16197896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pycroft</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Deep brain stimulation: An overview of history, methods, and future developments.</article-title>
            <source>Brain Neurosci Adv</source>
            <year>2018</year>
            <season>Jan-Dec</season>
            <volume>2</volume>
            <fpage>2398212818816017</fpage>
            <pub-id pub-id-type="pmid">32166163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buhmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huckhagel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gulberti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hidding</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Poetter-Nerger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goerendt</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ludewig</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Braass</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Choe</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>Krajewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oehlwein</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mittmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Gerloff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Westphal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>K&#x000f6;ppen</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Moll</surname>
                <given-names>CKE</given-names>
              </name>
              <name>
                <surname>Hamel</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>e0178984</fpage>
            <pub-id pub-id-type="pmid">28678830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20288.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bridges</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Odegard</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Maki</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Tomkowiak</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Interprofessional collaboration: three best practice models of interprofessional education.</article-title>
            <source>Med Educ Online</source>
            <year>2011</year>
            <month>Apr</month>
            <day>08</day>
            <volume>16</volume>
            <pub-id pub-id-type="pmid">21519399</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
